Abstract

Pentoxifylline 5% in Dermabase

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4

Page(s): 324

Download in electronic PDF format for $75
  • Pentoxifylline 5% in Dermabase Page 1

Abstract

A formulation for preparing Pentoxifylline 5% in Dermabase. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • pentoxifylline
  • synthetic xanthine derivative
  • blood viscosity
  • blood flow
  • perfusion
  • tissue oxygenation
  • ischemia
  • peripheral vascular disease
  • oxygen tension

Related Categories

  • FORMULATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2018
Pg. 324
Pentoxifylline 5% in Dermabase
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 70
Pentoxifylline 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Author(s): Riepl Mike
Jan/Feb 2012
Pg. 80-81
Chemical Stability of Pentoxifylline in a Topical Cream
Author(s): Gupta Vishnu D
May/Jun 2015
Pg. 252-260
Protocol of Blood Serum Eye Drops
Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
Jul/Aug 2020
Pg. 320
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jul/Aug 2003
Pg. 305-309
Quality-Control Analytical Methods: Viscosity Measurements
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 337-345
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Author(s): Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
Mar/Apr 2005
Pg. 117-119
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Author(s): Harrington Catherine A, Cauffield Jacintha
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jul/Aug 2011
Pg. 290-300
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Nov/Dec 1999
Pg. 443-446
Compounding Radiolabeled Blood Cells for Diagnostic Imaging
Author(s): Hinkle George H
Jan/Feb 2017
Pg. 47-56
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Author(s): Akers Michael J
May/Jun 2007
Pg. 252-258
Rheologic Profile, Specific Gravity, Surface Tension, and pH of Fifteen Over-the-Counter Preparations
Author(s): Al-Achi Antoine, Baghat Tushar, Chukwubeze Onah, Dembla Ishwin
Jul/Aug 2004
Pg. 301
Pentoxifylline 5% Topical Cream
Author(s): Allen Loyd V Jr
Jul/Aug 2024
Pg. 271-277
Combination Therapy of Oral LDN and Topical Pentoxifylline, Rifampin, Clindamycin for Hidradenitis Suppurativa
Author(s): Bertrand Joe, Bruno Matthew, Komuves Andrew, Jones Nat, Carper Kameryn, Banov Fabiana, Carvalho Maria
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Jul/Aug 2023
Pg. 284-293
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Author(s): Riepl Mike, Kaiser Joe
May/Jun 2011
Pg. 183-188
Home Infusion: Available Vascular Access Devices and Common Therapies
Author(s): Kennedy Steve, Williams LaVonn A